TRT and bodybuilding contest prep: separating protocol from hype
Quick answer
The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose. At 500mg/week, testosterone is well into supraphysiologic territory associated with HDL suppression, erythrocytosis, and potential cardiac remodeling, risks not addressed in the video. Any dose adjustment of exogenous testosterone should occur under direct provider supervision with baseline and follow-up labs including lipids, hematocrit, blood pressure, and estradiol.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @armonadibi actually say?
The creator responded to a follower who is already on 220mg of testosterone per week and wants bigger gains and more fat loss. The advice was direct: jump to 500mg per week, watch estrogen, possibly adjust an anti-estrogen, monitor red blood cell count, donate blood if needed, and stay at that higher dose for about six months before returning to a standard TRT dose. The phrase "really really good gains" was used twice, framing this as a reliable, low-drama upgrade.
This is not a gray area. A licensed provider recommending 220mg per week is already operating above what most endocrinology guidelines consider standard TRT. Advising an internet stranger to more than double that dose, based on no labs and no clinical intake, is a different category of risk entirely.
Does the science back this up?
The pharmacology is real, but the framing strips out the actual risk profile. Yes, higher testosterone doses produce more muscle and less fat. That part is documented. But the safety picture at 500mg per week looks nothing like the one at a supervised TRT dose.
A landmark NEJM study by Bhasin et al. (1996) showed dose-dependent muscle gains at supraphysiologic testosterone levels, but those subjects were monitored in a controlled setting. More relevant is the work of Coviello et al. (2008, Journal of Clinical Endocrinology and Metabolism), which demonstrated that testosterone doses above approximately 300mg per week substantially suppress HDL cholesterol, a cardiovascular risk factor that the creator did not mention at all. Rasmussen et al. (2016, European Heart Journal) and related research have linked long-term supraphysiologic androgen use to left ventricular hypertrophy and adverse cardiac remodeling. The creator's mention of monitoring hematocrit and donating blood is not wrong, but it addresses one risk while leaving cardiovascular, lipid, and hepatic considerations completely unaddressed.
What did they get wrong (or right)?
Credit where it is due: mentioning estrogen management and hematocrit monitoring reflects real clinical considerations. These are things providers actually track. Acknowledging that not everyone needs to donate blood is also accurate, individual response varies.
But here is what went wrong, and it matters. First, 500mg per week is not a TRT dose. It is a performance-enhancing dose used in bodybuilding cycles. Calling it a temporary increase before returning to "your regular TRT dose" blurs that line in a way that could lead someone to normalize pharmacological androgen use as routine hormone optimization. Second, no lipid panel discussion. No blood pressure mention. No acknowledgment that six months at 500mg per week is a meaningful cardiovascular exposure. Third, and most important, this advice was given to a stranger on TikTok with no clinical history, no recent labs reviewed on screen, and no provider relationship established. The creator says "I do get blood worked" as if that checkbox clears the path for a dose more than doubling.
What should you actually know?
If you are on TRT and want to optimize body composition, the conversation belongs with a prescribing provider who has your actual labs, not a TikTok comment section. Here is what that conversation should include.
- Hematocrit and hemoglobin, because supraphysiologic testosterone increases red blood cell mass and raises clotting risk.
- A full lipid panel. HDL suppression at higher doses is well-documented and cardiac risk accumulates silently.
- Blood pressure. Testosterone affects fluid retention and vascular tone.
- Estradiol levels, not just the assumption that an anti-estrogen might be needed.
- PSA if you are over 40.
The idea that you can run 500mg per week for six months and simply step back down to a TRT dose with no consequence is not supported by the pharmacology. Recovery of the hypothalamic-pituitary-gonadal axis at that suppression level is not guaranteed to be clean or fast, especially in someone already on exogenous testosterone long-term. A regulated telehealth provider can help you understand what optimization actually looks like within a monitored, legal framework.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT and bodybuilding contest prep: separating protocol from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
TRT and bodybuilding contest prep: separating protocol from hype should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose.
FormBlends verdict
The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose. At 500mg/week, testosterone is well into supraphysiologic territory associated with HDL suppression, erythrocytosis, and potential cardiac remodeling, risks not addressed in the video. Any dose adjustment of exogenous testosterone should occur under direct provider supervision with baseline and follow-up labs including lipids, hematocrit, blood pressure, and estradiol.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose. At 500mg/week, testosterone is well into supraphysiologic territory associated with HDL suppression, erythrocytosis, and potential cardiac remodeling, risks not addressed in the video. Any dose adjustment of exogenous testosterone should occur under direct provider supervision with baseline and follow-up labs including lipids, hematocrit, blood pressure, and estradiol.
- 500mg of testosterone per week is a supraphysiologic, performance-enhancing dose, not a modified TRT dose, and the distinction matters clinically.
- Bhasin et al. (1996, NEJM) confirmed dose-dependent anabolic effects of testosterone, but those subjects were under controlled monitoring, not self-directing based on social media advice.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 500mg of testosterone per week is a supraphysiologic, performance-enhancing dose, not a modified TRT dose, and the distinction matters clinically.
- Bhasin et al. (1996, NEJM) confirmed dose-dependent anabolic effects of testosterone, but those subjects were under controlled monitoring, not self-directing based on social media advice.
- Coviello et al. (2008, JCEM) found that doses above approximately 300mg per week significantly suppress HDL cholesterol, a cardiovascular risk the creator did not address.
- Long-term supraphysiologic androgen exposure is associated with left ventricular hypertrophy and adverse cardiac remodeling per Rasmussen et al. (2016, European Heart Journal).
- Hematocrit monitoring and blood donation are legitimate clinical tools for managing erythrocytosis, but they address only one of several serious risks at this dose level.
- Any adjustment to an exogenous testosterone regimen requires provider-supervised labs including lipids, hematocrit, blood pressure, estradiol, and PSA for appropriate candidates.
- HPG axis suppression at 500mg per week means return to baseline after cycling down is not guaranteed to be smooth, particularly in long-term testosterone users.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Armon Adibi · TikTok creator
42.0K views on this video
#answer to @lkwitter78 #sad #figure #bodybuilding #coach #contestprep #seromax #ifbb #npc #dietitian #fittok #adibiarmy #love #bestfriend #mma #powerlifting #npcjudge #winners #mensphysique #classicphysique #trt #hgh #hrt #wpd #health #death #driven #contestprep #natty #fakeinfluencer #fakecoaches #enhanced #supplementsthatwork #dominate
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Armon Adibi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.